- Home
- LAKE vs NKTX Comparison
LAKE vs NKTX Comparison
Compare LAKE & NKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAKE
- NKTX
- Stock Information
- Founded
- LAKE 1982
- NKTX 2015
- Country
- LAKE United States
- NKTX United States
- Employees
- LAKE N/A
- NKTX N/A
- Industry
- LAKE Industrial Specialties
- NKTX Biotechnology: Pharmaceutical Preparations
- Sector
- LAKE Health Care
- NKTX Health Care
- Exchange
- LAKE Nasdaq
- NKTX Nasdaq
- Market Cap
- LAKE 192.4M
- NKTX 170.8M
- IPO Year
- LAKE 1986
- NKTX 2020
- Fundamental
- Price
- LAKE $15.48
- NKTX $1.85
- Analyst Decision
- LAKE Strong Buy
- NKTX Strong Buy
- Analyst Count
- LAKE 3
- NKTX 6
- Target Price
- LAKE $26.00
- NKTX $15.00
- AVG Volume (30 Days)
- LAKE 95.0K
- NKTX 2.5M
- Earning Date
- LAKE 04-09-2025
- NKTX 05-08-2025
- Dividend Yield
- LAKE 0.78%
- NKTX N/A
- EPS Growth
- LAKE N/A
- NKTX N/A
- EPS
- LAKE N/A
- NKTX N/A
- Revenue
- LAKE $167,211,000.00
- NKTX N/A
- Revenue This Year
- LAKE $26.83
- NKTX N/A
- Revenue Next Year
- LAKE $4.32
- NKTX N/A
- P/E Ratio
- LAKE N/A
- NKTX N/A
- Revenue Growth
- LAKE 34.10
- NKTX N/A
- 52 Week Low
- LAKE $14.58
- NKTX $1.31
- 52 Week High
- LAKE $27.28
- NKTX $8.33
- Technical
- Relative Strength Index (RSI)
- LAKE 33.34
- NKTX 56.56
- Support Level
- LAKE $15.38
- NKTX $1.67
- Resistance Level
- LAKE $16.56
- NKTX $1.84
- Average True Range (ATR)
- LAKE 1.52
- NKTX 0.14
- MACD
- LAKE -0.15
- NKTX 0.03
- Stochastic Oscillator
- LAKE 14.40
- NKTX 75.44
About LAKE Lakeland Industries Inc.
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
About NKTX Nkarta Inc.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.